Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Klaassen, ES"'
Autor:
Nieuwenhoff MD; Department of Anesthesiology and Pain Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Centre for Human Drug Research, Leiden, The Netherlands., Nguyen HT; Department of Ophthalmology, Amsterdam UMC location VU University Medical Center, Amsterdam, The Netherlands., Niehof SP; Department of Anesthesiology and Pain Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Huygen FJPM; Department of Anesthesiology and Pain Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Verma A; Biogen, Cambridge, Massachusetts, USA., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Bechakra M; Department of Anesthesiology and Pain Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Geelhoed WJ; Centre for Human Drug Research, Leiden, The Netherlands., Jongen JLM; Department of Anesthesiology and Pain Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Moll AC; Department of Ophthalmology, Amsterdam UMC location VU University Medical Center, Amsterdam, The Netherlands., Vrancken AFJE; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands., Petzold A; Department of Ophthalmology, Amsterdam UMC location VU University Medical Center, Amsterdam, The Netherlands.; Department of Neurology, Amsterdam UMC location VU University Medical Center, Amsterdam, The Netherlands.; Moorfields Eye Hospital, The National Hospital for Neurology and Neurosurgery and the Queen Square Institute of Neurology, UCL, London, UK., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Muscle & nerve [Muscle Nerve] 2024 Oct; Vol. 70 (4), pp. 782-790. Date of Electronic Publication: 2024 Jul 26.
Autor:
Yfanti C; Centre for Human Drug Research, Leiden, the Netherlands., Vestbjerg B; Acesion Pharma ApS, Copenhagen, Denmark., Van't Westende J; Centre for Human Drug Research, Leiden, the Netherlands., Edvardsson N; Acesion Pharma ApS, Copenhagen, Denmark.; Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Monfort LM; Department of Biomedical Sciences, University of Copenhagen, Denmark., Olesen MS; Department of Biomedical Sciences, University of Copenhagen, Denmark., Bentzen BH; Acesion Pharma ApS, Copenhagen, Denmark.; Department of Biomedical Sciences, University of Copenhagen, Denmark., Grunnet M; Acesion Pharma ApS, Copenhagen, Denmark., Eveleens Maarse BC; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Centre, Leiden, the Netherlands., Diness JG; Acesion Pharma ApS, Copenhagen, Denmark., Kemme MJB; Cardiology department, Amsterdam UMC, Amsterdam, the Netherlands., Sørensen U; Acesion Pharma ApS, Copenhagen, Denmark., Moerland M; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Centre, Leiden, the Netherlands., van Esdonk MJ; Centre for Human Drug Research, Leiden, the Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, the Netherlands., Gal P; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Centre, Leiden, the Netherlands., Holst AG; Acesion Pharma ApS, Copenhagen, Denmark.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Apr; Vol. 90 (4), pp. 1027-1035. Date of Electronic Publication: 2024 Jan 08.
Autor:
Eveleens Maarse BC; Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands.; Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Ronner MN; Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands.; Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Jansen MAA; Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands., Niemeyer-van der Kolk T; Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands.; Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., In 't Veld AE; Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands.; Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands., Ahmad S; Evelo Biosciences Inc., One Kendall Square, Building 600/700, Suite 7-201, Cambridge, MA, USA.; Veramed, 5th Floor Regal House, 70 London Road, Twickenham, TW1 3QS, UK., Itano A; Evelo Biosciences Inc., One Kendall Square, Building 600/700, Suite 7-201, Cambridge, MA, USA., McHale D; Evelo Biosciences Inc., One Kendall Square, Building 600/700, Suite 7-201, Cambridge, MA, USA., Moerland M; Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands. mmoerland@chdr.nl.; Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. mmoerland@chdr.nl.
Publikováno v:
Immunologic research [Immunol Res] 2024 Aug; Vol. 72 (4), pp. 776-787. Date of Electronic Publication: 2024 May 15.
Autor:
van Kraaij SJW; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Surgery, Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands., Borghans L; Centre for Human Drug Research, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Gal P; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Surgery, Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands., van der Grond J; Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands., Tripp K; Cyclerion Therapeutics, Cambridge, Massachusetts, USA., Winrow C; Cyclerion Therapeutics, Cambridge, Massachusetts, USA., Glasser C; Cyclerion Therapeutics, Cambridge, Massachusetts, USA., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Surgery, Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Dec; Vol. 89 (12), pp. 3606-3617. Date of Electronic Publication: 2023 Aug 13.
Autor:
van Kraaij SJW; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Gal P; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Borghans LGJM; Centre for Human Drug Research, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Dijkstra F; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Winrow C; Cyclerion Therapeutics, Cambridge, Massachusetts, USA., Glasser C; Cyclerion Therapeutics, Cambridge, Massachusetts, USA., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2023 Aug; Vol. 16 (8), pp. 1381-1395. Date of Electronic Publication: 2023 May 03.
Autor:
van Minderhout HM; Department of Ophthalmology, Haaglanden Medical Centre, The Hague.; Department of Ophthalmology, Paediatric Ophthalmology, Leiden University Medical Centre, Leiden., Joosse MV; Department of Ophthalmology, Haaglanden Medical Centre, The Hague., Klaassen ES; Department of Statistics, Centre for Human Drug Research, Leiden., Schalij-Delfos NE; Department of Ophthalmology, Paediatric Ophthalmology, Leiden University Medical Centre, Leiden.
Publikováno v:
Strabismus [Strabismus] 2023 Jun; Vol. 31 (2), pp. 82-96. Date of Electronic Publication: 2023 Jun 06.
Autor:
Saghari M; Centre for Human Drug Research (CHDR), Leiden, Netherlands.; Leiden University Medical Centre (LUMC), Leiden, Netherlands., Gal P; Centre for Human Drug Research (CHDR), Leiden, Netherlands.; Leiden University Medical Centre (LUMC), Leiden, Netherlands., Grievink HW; Centre for Human Drug Research (CHDR), Leiden, Netherlands.; Leiden Academic Centre for Drug Research (LACDR), Leiden, Netherlands., Klaassen ES; Centre for Human Drug Research (CHDR), Leiden, Netherlands., Itano A; Evelo Biosciences Inc., Cambridge, MA, United States., McHale D; Evelo Biosciences Inc., Cambridge, MA, United States., Moerland M; Centre for Human Drug Research (CHDR), Leiden, Netherlands.; Leiden University Medical Centre (LUMC), Leiden, Netherlands.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Dec 07; Vol. 13, pp. 1009304. Date of Electronic Publication: 2022 Dec 07 (Print Publication: 2022).
Autor:
Pagan L; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Gynaecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands., Yfanti C; Centre for Human Drug Research, Leiden, The Netherlands., Rijneveld R; Centre for Human Drug Research, Leiden, The Netherlands., Todd M; Centre for Human Drug Research, Leiden, The Netherlands., Jongste P; Centre for Human Drug Research, Leiden, The Netherlands., Feijen JJ; Centre for Human Drug Research, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Bouwes Bavinck JN; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands., Struijk L; Viroclinics-DDL, DDL Diagnostic Laboratory, Rijswijk, The Netherlands., de Koning MNC; Viroclinics-DDL, DDL Diagnostic Laboratory, Rijswijk, The Netherlands., Prestegarden L; Cytovation AS, Bergen, Norway., Niemeyer-van der Kolk T; Centre for Human Drug Research, Leiden, The Netherlands., van Poelgeest MIE; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Gynaecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlands., Rissmann R; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Leiden Skin Institute, Leiden, The Netherlands.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Oct; Vol. 36 (10), pp. e773-e775. Date of Electronic Publication: 2022 Jun 14.
Autor:
Saghari M; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Gal P; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Gilbert S; Kymab Ltd., Cambridge, UK., Yateman M; Kymab Ltd., Cambridge, UK., Porter-Brown B; Kymab Ltd., Cambridge, UK., Brennan N; Kymab Ltd., Cambridge, UK., Quaratino S; Kymab Ltd., Cambridge, UK., Wilson R; Kymab Ltd., Cambridge, UK., Grievink HW; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden, The Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, The Netherlands., Bergmann KR; Centre for Human Drug Research, Leiden, The Netherlands., Burggraaf J; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden, The Netherlands., van Doorn MBA; Centre for Human Drug Research, Leiden, The Netherlands.; Department of Dermatology, Erasmus Medical Centre, Rotterdam, The Netherlands., Powell J; Kymab Ltd., Cambridge, UK., Moerland M; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands., Rissmann R; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Centre, Leiden, The Netherlands.; Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 May; Vol. 111 (5), pp. 1121-1132. Date of Electronic Publication: 2022 Mar 01.
Autor:
Moss LM; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University, Leiden, the Netherlands., Berends CL; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University, Leiden, the Netherlands., van Brummelen EMJ; Centre for Human Drug Research, Leiden, the Netherlands., Kamerling IMC; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University, Leiden, the Netherlands., Klaassen ES; Centre for Human Drug Research, Leiden, the Netherlands., Bergmann K; Centre for Human Drug Research, Leiden, the Netherlands., Ville V; Stragen France, Lyon, France., Juarez-Perez V; Stragen France, Lyon, France., Benichou AC; Stragen Services, Lyon, France., Groeneveld GJ; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University, Leiden, the Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jan; Vol. 88 (1), pp. 103-114. Date of Electronic Publication: 2021 Jul 16.